BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld
BioWorld
May 20, 2004
View Archived Issues
Phase III Antegren Data Show Benefit For Crohn's Continues
Offering new data for Antegren against Crohn's disease, Biogen Idec Inc. said it will file for approval in the European Union but is conducting another study in the U.S. before seeking approval here. (BioWorld Today)
Read More
Senate Passes BioShield In 99-0 Vote; $5.6B Slated For Industry
Read More
Two Companies Spun Out Of Seattle Incubator Organization
Read More
J&J, Centocor Acquiring Egea For Protein Design Technology
Read More
Other News To Note
Read More
Appointments And Advancements
Read More